Last week the FDA approved two drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with unresectable (cannot be removed by surgery) or advanced melanoma. This type of skin cancer is… read more →
GlaxoSmithKline (GSK) will join Save the Children in order to fight the leading causes of childhood death worldwide. GSK will donate $23 million dollars during this 5-year partnership, the main… read more →
It is often difficult to enroll patients in clinical trials, a problem that is seen in research worldwide. One reason for this underwhelming participation is a lack of public trust. … read more →
A drug that failed to treat sepsis in clinical trials may provide a new way to fight the flu. Tests on rats have shown that the drug may stop the… read more →
Want to hear more from us about upcoming and currently enrolling studies, industry news, and health topics? Follow us on twitter and friend us on facebook! We are also now on Google+.